GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care

April 7, 2026 updated by: Michael Stewart

GUT LINK: A Pilot Study to Evaluate the Comparative Effectiveness of an Evidence-based Care Pathway Across Primary and GI Specialty Care

It can be challenging for Primary Healthcare Providers (PHCPs) to differentiate between IBS and more serious illnesses involving the GI tract, such as Crohn's disease, ulcerative colitis, or cancer. To help with diagnosis and treatment of IBS, evidence-based guidelines have been developed. However, they are not commonly used in primary care practice and PHCPs and patients often feel that GI specialist evaluation and endoscopy is required. The development of care pathways and clinical practice guidelines is essential to support the investigation and management of digestive diseases, such as IBS.

The current pilot study is designed to assess the implementation and early comparative effectiveness of a Clinical Care Pathway for lower GI tract symptoms.

Study Overview

Status

Withdrawn

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3N 2Z6
        • QEII Health Sciences Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Must be a general practitioner
  • Have a family practice in Nova Scotia, Canada
  • Utilize the platform 'virtual hallway' as part of current referral practices
  • Deliver care to patients with lower GI complaints

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GUT LINK SmartPath
physicians will use the interactive GUT LINK Smartpath tool in virtual hallway platform to guide their care and referral practices
A virtual care delivery and referral support tool for primary healthcare providers.
No Intervention: control
physicians will provide care and refer as per their usual practices

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of users
Time Frame: month 3
Number of users (an indicator of prototype acceptability)
month 3
Number of users
Time Frame: month 6
Number of users (an indicator of prototype acceptability)
month 6
Number of referrals
Time Frame: month 3
Number of referrals from GPs to GI Department (an indicator of prototype acceptability)
month 3
Number of referrals
Time Frame: month 6
Number of referrals from GPs to GI Department (an indicator of prototype acceptability)
month 6
Number of referrals per week
Time Frame: month 3
Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
month 3
Number of referrals per week
Time Frame: month 6
Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
month 6
Number of referrals per user
Time Frame: month 3
Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
month 3
Number of referrals per user
Time Frame: month 6
Number of referrals per week from GPs to GI Department (an indicator of prototype acceptability)
month 6
Number of clicks per referral
Time Frame: month 3
Number of clicks per referral from GPs to GI Department (an indicator of prototype acceptability)
month 3
Number of clicks per referral
Time Frame: month 6
Number of clicks per referral from GPs to GI Department (an indicator of prototype acceptability)
month 6
Primary Healthcare Provider Satisfaction
Time Frame: baseline (month 0)
Thematic analysis of interviews of primary care providers will yield key themes related to satisfaction with the intervention.
baseline (month 0)
Primary Healthcare Provider Satisfaction
Time Frame: month 6
Thematic analysis of interviews of primary care providers will yield key themes related to satisfaction with the intervention.
month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number referrals received as per prototype
Time Frame: month 3
Number referrals received as per prototype (an implementation metric)
month 3
Number referrals received as per prototype
Time Frame: month 6
Number referrals received as per prototype (an implementation metric)
month 6
Number of referrals received requiring troubleshooting
Time Frame: month 3
Number of referrals received requiring troubleshooting (an implementation metric)
month 3
Number of referrals received requiring troubleshooting
Time Frame: month 6
Number of referrals received requiring troubleshooting (an implementation metric)
month 6
Number of referrals aborted
Time Frame: month 3
Number of referrals aborted (an implementation metric)
month 3
Number of referrals aborted
Time Frame: month 6
Number of referrals aborted (an implementation metric)
month 6
Type of consult
Time Frame: month 3
Type of consult (Full consult, specialist telephone advice, eConsult)
month 3
Type of consult
Time Frame: month 6
Type of consult (Full consult, specialist telephone advice, eConsult)
month 6
Perceived appropriateness of the SmartPath
Time Frame: month 3
Thematic analysis of interviews of primary care providers will yield key themes related to the perceived appropriateness of the intervention
month 3
Perceived appropriateness of the SmartPath
Time Frame: month 6
Thematic analysis of interviews of primary care providers will yield key themes related to the perceived appropriateness of the intervention
month 6
physician self-efficacy rating
Time Frame: month 3
physician self-efficacy rating, measured using the 'New General Self Efficacy Scale' (an effectiveness metric of GUT LINK Smartpath). Min score: 1, max score: 8. A higher score indicates a greater self-efficacy.
month 3
physician self-efficacy rating
Time Frame: month 6
physician self-efficacy rating, measured using the 'New General Self Efficacy Scale' (an effectiveness metric of GUT LINK Smartpath). Min score: 1, max score: 8. A higher score indicates a greater self-efficacy.
month 6
Referral triage priority category
Time Frame: month 3
Referral triage priority category will be collected from referrals through the pathway (an effectiveness metric of GUT LINK Smartpath). Referral triage categories to the GI department are: emergent, semi urgent, and non-urgent.
month 3
Referral triage priority category
Time Frame: month 6
Referral triage priority category will be collected from referrals through the pathway (an effectiveness metric of GUT LINK Smartpath). Referral triage categories to the GI department are: emergent, semi urgent, and non-urgent.
month 6
Time from referral to specialist consultation
Time Frame: month 3
Time from referral to specialist consultation, in weeks (an effectiveness metric of GUT LINK Smartpath)
month 3
Time from referral to specialist consultation
Time Frame: month 6
Time from referral to specialist consultation, in weeks (an effectiveness metric of GUT LINK Smartpath)
month 6
Time from referral to diagnosis and treatment
Time Frame: month 3
Time from referral to diagnosis and treatment, in weeks (an effectiveness metric of GUT LINK Smartpath)
month 3
Time from referral to diagnosis and treatment
Time Frame: month 6
Time from referral to diagnosis and treatment, in weeks (an effectiveness metric of GUT LINK Smartpath)
month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2024

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

January 23, 2023

First Submitted That Met QC Criteria

February 10, 2023

First Posted (Actual)

February 13, 2023

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe